Women’s health outcomes depend on timely screening, dignified care, and reliable diagnostics—yet many women across Zambia face delays, fragmented services, and high total costs when they must travel repeatedly or pay multiple providers for the same pathway. Lusaka WomenCare Health Clinic Ltd is designed to solve these pain points by delivering a women-only care pathway with structured triage, in-clinic consultations, and test-and-treat services linked to laboratory testing and follow-up scheduling.
The clinic will be located in Lusaka, Zambia and operated as a Zambian Private Limited company (Ltd). Our offering targets women aged 18–49 within 30–45 minutes of central Lusaka, with emphasis on working mothers, informal workers, and young women who need discreet appointments and dependable results. The business model combines revenue from consultations, screening packages, and test-and-treat services, supported by marketing that builds trust through community education, partner referrals, and repeat booking.
Financially, the plan is built on a five-year model with steady growth to reach ZMW 4,580,378 in total revenue by Year 5. The model shows the clinic reaching operating stability within Year 1 and generating positive net income from Year 1 onward, with break-even timing in Month 1 (within Year 1). This document presents the market, differentiation, operating system, and financial projections needed for investors and lenders to assess viability and funding readiness.
Executive Summary
Lusaka WomenCare Health Clinic Ltd will provide timely, women-centered healthcare services focused on common conditions affecting reproductive and sexual health. The clinic’s strategy is to reduce delayed and expensive care by ensuring that women can access the right level of service quickly: consultation, triage, screening where appropriate, diagnostic testing through our laboratory-linked pathway, and treatment plans with clear follow-up dates. The business is intentionally structured around a “care pathway” approach—so patients experience continuity instead of having to navigate multiple providers, pay repeated fees, or wait indefinitely for results.
Core problem and solution
In Lusaka, many women experience healthcare friction that increases the total burden on families: long public facility queues, limited women-focused continuity, and private care that can feel fragmented. These conditions lead to delayed diagnosis and, in some cases, preventable progression of disease. Lusaka WomenCare Health Clinic Ltd addresses these gaps through:
- Same-week appointments for urgent concerns through a scheduling and triage workflow.
- Structured follow-up after lab-based testing so women return at the recommended time window.
- Women-only pathway services that improve comfort, privacy, and communication clarity.
Target customers and value proposition
Our primary customers are women aged 18–49 in Lusaka and surrounding areas who live within 30–45 minutes of central Lusaka. Many are low-to-middle income, including working mothers and informal workers. They seek discreet appointments and trusted outcomes, particularly for:
- Abnormal uterine bleeding
- Cervical pre-cancer screening and follow-up
- STIs and reproductive health concerns
- Reproductive health needs requiring diagnosis and ongoing care planning
The clinic differentiates by combining clinical capability (nurse-led triage, clinician-part-time services, diagnostics coordination) with operational discipline (appointment scheduling systems, specimen/result tracking routines, and patient experience management).
Business model
Revenue is generated through:
- Patient visits that include consultation fees
- Screening packages
- Test-and-treat services linked to lab testing and in-clinic treatment planning
The model maintains a consistent 62.0% gross margin assumption across the projection horizon. This supports sustainable operations while funding growth, staffing additions, and expanded service capacity over time.
Growth and financial viability
The five-year projection model shows total revenue increasing from ZMW 1,476,000 in Year 1 to ZMW 4,580,378 in Year 5. The clinic remains profitable throughout the model horizon with net income rising from ZMW 245,648 in Year 1 to ZMW 1,383,296 in Year 5.
Break-even analysis indicates the clinic reaches break-even revenue of ZMW 866,452 on an annual basis, with break-even timing in Month 1 (within Year 1). This timing is driven by planned ramp-up through community referrals, monthly screening days, and structured repeat follow-up.
Funding request and use of funds
The plan requests ZMW 180,000 total funding, structured as:
- Equity capital: ZMW 60,000
- Debt principal: ZMW 120,000
The funds are allocated to clinic build-out and preparation (fit-out, furniture, equipment, IT, initial inventory, deposits, and compliance/registration) and to provide liquidity during the early ramp-up period.
Why now
Women’s healthcare demand grows steadily as Lusaka’s urban population expands and as awareness of reproductive health and cancer prevention increases. Yet service gaps persist—especially in continuity, follow-up compliance, and women-only care pathways. Lusaka WomenCare Health Clinic Ltd is positioned to capitalize on this gap with a clear model: timely access, diagnostic reliability, and patient follow-through.
Company Description
Business Name: Lusaka WomenCare Health Clinic Ltd
Location: Lusaka, Zambia
Legal Structure: Zambian Private Limited company (Ltd)
Invoicing Currency: ZMW (Zambian Kwacha)
Mission and vision
The mission of Lusaka WomenCare Health Clinic Ltd is to improve women’s health outcomes in Lusaka by offering accessible, timely, and dignified services across screening, diagnosis, and treatment. The clinic exists to reduce the cost of delay—for patients and for families—by ensuring that women can access a structured care pathway rather than fragmented episodes.
The clinic’s vision is to become a trusted women’s health partner for women aged 18–49 in Lusaka—known for discreet appointments, reliable lab-linked results, and follow-up that is scheduled in advance rather than postponed indefinitely.
Value proposition and differentiation
The clinic’s differentiated value proposition is grounded in operational design, not only medical intention. Competitors may provide individual services (for example, diagnostics or general consultations), but Lusaka WomenCare Health Clinic Ltd is designed to deliver an integrated women-focused experience.
Our differentiation includes:
- Women-only pathway services that prioritize comfort, privacy, and communication.
- Same-week appointments for urgent concerns, supported by triage and scheduling routines.
- Structured follow-up after results through appointment reminders and tracking.
- Monthly community education and screening days to convert awareness into booked visits quickly.
Service philosophy: timely, complete, and continuous care
Women often need care in stages: initial consultation, possible screening, diagnostic confirmation, treatment decisions, and follow-up monitoring. The clinic’s care philosophy ensures that these stages are connected:
- Consultation and triage determine the pathway immediately.
- Diagnostic steps are arranged without unnecessary delays.
- Test results trigger planned follow-up and next-step scheduling.
- Patient experience staff ensure women complete the loop.
This reduces the “drop-off” problem common in healthcare pathways, where women may not return after tests due to cost, transportation barriers, or uncertainty about results. The clinic’s structured follow-up mitigates this risk.
Ownership and organizational accountability
The clinic will be owned and led by:
- Oskar Marshall (Founder/Owner)
The management structure includes clinical operations, lab diagnostics liaison, patient experience and administration, and compliance/procurement roles. These roles are designed to maintain consistent quality and operational discipline even as patient volumes scale.
Strategic location rationale: Lusaka
Lusaka is the target geography for multiple reasons: concentration of services, urban population density, and the presence of many working women whose time constraints increase the value of fast appointments and fewer repeat visits.
Clinic placement is intended to remain accessible for women who rely on public transport or shared transport systems. The clinic’s operational design assumes that patients live within a 30–45 minute travel window to minimize no-shows and improve follow-up completion rates.
Products / Services
Lusaka WomenCare Health Clinic Ltd will offer a women-centered service lineup that combines direct clinical care with diagnostic coordination and structured follow-up. The clinic’s service portfolio is designed around patient journeys for conditions and needs commonly reported by women aged 18–49.
Service categories and patient pathways
1. On-site consultations and triage
The clinic provides in-clinic consultations focused on reproductive health, sexual health, and related gynecological concerns. Consultations are supported by a triage workflow that determines:
- Whether immediate treatment is appropriate
- Whether screening is indicated
- Whether diagnostic testing is required
- The best follow-up schedule for results and treatment adjustments
Consultation use cases include:
- Abnormal uterine bleeding (initial assessment, history taking, and pathway planning)
- STI-related symptoms (triage, counseling, testing recommendations)
- Cervical screening and pre-cancer evaluation follow-up pathways
- General reproductive health needs requiring diagnostic clarification
Consultation appointments are designed to be discreet and women-only in pathway experience.
2. Screening packages (women’s health prevention and early detection)
The clinic will run screening-focused visits and packages aimed at early detection and risk management. Screening packages are operationally important because they drive both diagnostic certainty and repeat follow-up.
Screening packages typically include:
- A structured screening consultation
- Health education and counseling tailored to the patient’s situation
- Scheduling of follow-up appointments aligned to the test turnaround and clinical recommendations
To translate awareness into attendance, the clinic will also run monthly community education and screening days at community venues, generating bookings for screening and follow-up.
3. Test-and-treat services linked to lab-based testing
Many women’s health conditions require laboratory confirmation. Lusaka WomenCare Health Clinic Ltd will coordinate lab-based testing via a partner lab workflow.
Test-and-treat services include:
- Specimen preparation and courier/transport coordination
- Lab-based testing via our laboratory-linked pathway
- Result review and patient counseling
- Treatment plan initiation or adjustment
- Follow-up scheduling based on recommended windows
This model reduces patient burden by enabling women to complete diagnostic steps within a single care pathway rather than navigating multiple providers.
4. Ultrasound referrals and diagnostics escalation
Some cases require diagnostic escalation beyond in-clinic capabilities. The clinic will arrange ultrasound referrals when clinically indicated, ensuring that:
- The referral decision is recorded
- The patient receives clear instructions
- Follow-up is scheduled for interpretation and next steps
Ultrasound referrals are not billed as standalone services in isolation; they function as part of a continuous clinical pathway.
5. Reproductive health counseling and follow-up compliance
Women often need time, clarity, and assurance—especially after tests or when results require lifestyle, treatment adherence, or additional monitoring. The clinic will emphasize counseling that includes:
- Clear communication of results
- Explanation of next steps
- Scheduled follow-up dates
- Reminders aligned with patient ability to attend
The patient experience function manages scheduling and tracking to reduce missed appointments.
Service delivery system: step-by-step
Lusaka WomenCare Health Clinic Ltd will standardize delivery so outcomes remain consistent and scalable.
Step 1: Appointment booking and pre-visit confirmation
- Patients book via channels such as WhatsApp and Facebook marketing touchpoints, referrals, website/Google Business Profile prompts, or direct phone inquiries.
- Admin staff confirm appointment time, arrival instructions, and expected process.
Step 2: In-clinic consultation
- Registered nurse triage supports clinical intake.
- Clinician-part-time consultations cover specific diagnosis and treatment planning.
Step 3: Determine pathway
- If tests are required, the clinic confirms specimen type and instructions.
- If screening is indicated, the clinic schedules screening steps and follow-up.
Step 4: Diagnostics coordination
- Specimens are prepared.
- Lab testing is coordinated through partner lab routines.
- Courier/fees are managed as a variable cost component that scales with test volume.
Step 5: Results review and patient counseling
- Results trigger follow-up calls or appointment scheduling.
- Treatment plan is adjusted based on findings.
Step 6: Follow-up schedule
- Follow-up is scheduled at booking time where possible.
- Return visit incentives may be used to strengthen follow-through (as described qualitatively in the owner’s initial planning approach).
Clinical quality principles
Women’s health requires trust. Clinical quality principles embedded in the service design include:
- Triage consistency so urgent cases are addressed quickly
- Counseling clarity so patients understand why next steps matter
- Documentation and specimen/result tracking so information remains accurate across visits
- Compliance and procurement control so medical supplies and consumables are available without stockouts
Service promise: what patients can expect
Patients should experience:
- Discreet, women-focused interaction
- Fast scheduling, including same-week options for urgent concerns
- Clear pricing and next steps before testing and treatment decisions proceed
- Follow-up appointments tied to results and clinical recommendations
This service promise reduces uncertainty, which is a major contributor to delayed care.
Market Analysis
Zambia’s healthcare sector includes public hospitals, faith-based providers, independent clinics, and diagnostic centers. In reproductive and women’s health, demand is driven by demographic structure, rising awareness of screening, and increasing patient willingness to pay for private care where access delays exist.
Target market definition
Primary customer segment
The clinic’s primary segment is women aged 18–49 in Lusaka and nearby areas within 30–45 minutes of central Lusaka. Many customers are:
- Working mothers and caregivers
- Informal workers with unpredictable schedules
- Young women requiring discrete, confidential appointments
- Women seeking reliable diagnostic results and structured follow-up
Customer needs and buying behavior
Women choose clinics based on:
- Time to appointment and test scheduling
- Trustworthiness of results
- Discretion and perceived dignity of care
- Continuity—whether the clinic helps them complete the full pathway
- Ease of navigating treatment recommendations
In many cases, women switch providers when care is fragmented or when results are not followed up clearly. Lusaka WomenCare Health Clinic Ltd is built to reduce that switching by maintaining a care pathway.
Market sizing logic
To estimate market opportunity, this plan uses a practical demographic approach. Lusaka has a large urban population with a steady base of women of reproductive age. The estimated number of potential women customers is 250,000 women aged 18–49 in Greater Lusaka.
This market sizing is not based on clinical demand alone; it also considers accessibility. Since the clinic targets women within 30–45 minutes of central Lusaka, the relevant portion of the broader population is the set of women likely to travel for private care at reasonable time and transportation cost.
Market segment priorities
Not all demand converts equally. The clinic’s early go-to-market focuses on “care pathway urgency,” such as:
- Abnormal uterine bleeding concerns where patients seek faster assessment
- Cervical pre-cancer screening and follow-up due to awareness growth
- STI symptom management where timely diagnosis reduces discomfort and transmission risk
- Reproductive health concerns needing diagnostic clarity
These conditions align with a clinic’s ability to deliver same-week appointments and scheduled follow-up.
Competitive landscape in Lusaka
Key competitor types
Competitors fall into distinct categories:
-
Armed Forces hospitals/private sections
- Strength: clinical reputation
- Constraint: access may be limited for some clients due to eligibility rules or appointment access dynamics
-
Lusaka private GP and general clinics
- Strength: broad medical presence
- Constraint: women’s health specialization may be limited; follow-up pathways may not be as structured
-
Independent diagnostic centers and lab-focused clinics
- Strength: diagnostic capability
- Constraint: may not provide end-to-end women’s health care and structured counseling/treatment planning
Competitive gap and differentiation strategy
Lusaka WomenCare Health Clinic Ltd differentiates by combining:
- Women-only pathway services
- Same-week appointments (where clinically appropriate)
- Structured follow-up after results
Additionally, community-based education and screening days translate awareness into bookings, reducing the “marketing cost per appointment” in early ramp-up.
Demand drivers
Demographic demand and health awareness
Urbanization supports steady healthcare demand. As awareness grows—particularly around cervical screening, STI prevention, and symptom management—more women seek diagnostic clarity earlier rather than after delays.
Economic constraints and value-for-money care
Many women face constrained budgets. Public facility waiting times can be incompatible with work schedules. Private care can be costly, but women will pay when they:
- Reduce repeat visits
- Receive timely results
- Know what next step they must take
- Receive guidance that reduces uncertainty
This plan’s care pathway design is structured to improve total value.
Market risks and counterpoints
Risk 1: Trust and adoption friction
A new clinic may face “trial risk.” Women may be cautious about trying an unknown provider, particularly for sensitive services.
Mitigation:
- Build trust through community education and screening days
- Leverage referral partnerships (pharmacies, community health volunteers, women’s groups)
- Maintain structured follow-up to demonstrate reliability
Risk 2: Lab turnaround delays
If results take longer than patients expect, follow-up booking rates could suffer.
Mitigation:
- Use a lab liaison function (Taylor Nguyen as Lab & Diagnostics Liaison) for result tracking routines
- Implement scheduling expectations at booking
- Maintain appointment reminders and follow-up workflows for timely closure
Risk 3: Price sensitivity
Customers may compare costs across providers and delay testing.
Mitigation:
- Provide clear pricing and transparent next steps
- Emphasize the “total pathway value” (fewer repeat trips, integrated care planning)
- Use screening day bundles and return-visit incentives to reduce friction
Market opportunity conclusion
Lusaka WomenCare Health Clinic Ltd has a clear opportunity to occupy a “women-only integrated pathway” position. Competition exists, but the clinic’s strategic advantage is not just offering tests—it is delivering timely screening, diagnosis, and treatment with structured follow-up in a women-centered experience. With a target market of 250,000 women aged 18–49 in Greater Lusaka, there is enough depth to support multi-year scaling while maintaining financial viability.
Marketing & Sales Plan
The clinic’s marketing and sales plan is built to create predictable appointment flow while reinforcing trust and repeat behavior. Women’s health demand is sensitive to reputation, discretion, and the clarity of next steps. Therefore, the marketing strategy emphasizes reliability and follow-through rather than aggressive selling.
Marketing objectives
In Year 1 and beyond, the clinic focuses on:
- Building awareness among women aged 18–49 within Lusaka.
- Converting awareness into bookings through clear channels and community education.
- Increasing follow-up completion rates through scheduled appointments and reminders.
- Strengthening referral partnerships with local trusted organizations.
Target customer marketing strategy
Core channels
Marketing will be delivered through a mix of digital and community channels, including:
- WhatsApp and Facebook marketing for women’s health education, appointment reminders, and result follow-ups
- Referral partnerships with local pharmacies, community health volunteers, and women’s groups
- Monthly community education and screening days to generate booked visits quickly
- A clinic website and Google Business Profile for directions, service lists, and call-to-book conversions
This channel mix is designed to serve both first-time and returning patients.
Sales approach: consultative and pathway-based
The clinic’s sales approach is not pushy. It is structured around clarity:
- During consultations, staff explain the clinical pathway and why testing or screening is recommended.
- Patients receive clear instructions for tests and expected timelines.
- Follow-up appointments are planned and confirmed.
To increase conversion, the clinic will standardize how staff communicate:
- The reason for any recommended test or screening step
- The expected benefit (e.g., confirmation, risk management, treatment decisions)
- The follow-up schedule tied to results
Packaging and offer strategy
Marketing packages support conversion by simplifying decision-making. The clinic will use:
- Screening packages as entry points for prevention and early detection.
- Test-and-treat services as follow-through for conditions requiring diagnostic confirmation.
This packaging approach allows the clinic to show the full pathway value.
Marketing calendar and execution detail
Monthly rhythm
Each month includes:
- A community education activity and screening day event
- Follow-up messaging campaigns via WhatsApp/Facebook
- Referral partner check-ins and ongoing relationship building
- Website and Google Business Profile updates (service descriptions, appointment instructions, location clarity)
Launch-phase actions
During initial launch:
- The clinic uses a “trust first” sequence—education and partner introductions before scaling high-volume advertising.
- Community screening days are scheduled early to generate momentum and evidence of reliability.
Sales conversion mechanisms
Scheduling systems and reminders
A significant share of conversion happens after first contact. The clinic’s process ensures that:
- Patients receive appointment confirmation
- Result follow-up is scheduled at the end of the first visit where possible
- Reminders are sent through WhatsApp messages
Return visit incentives (qualitative positioning)
The clinic will use return-visit incentives to strengthen completion of follow-up pathways within recommended windows. Incentives are structured to reward completion, not attendance alone.
Competitive positioning in messaging
Messaging will directly address gaps in the market:
- “Fast access” (same-week appointments for urgent concerns)
- “Women-only experience”
- “Clear next steps after tests”
- “Follow-up that is scheduled, not left to chance”
This messaging aligns with the clinic’s differentiation and creates a coherent narrative for marketing campaigns.
Measurement and KPIs
The marketing and sales plan will track:
- Number of leads by channel (WhatsApp/Facebook inquiries, referral partners, website/Google Business Profile calls)
- Appointment conversion rate (leads to booked visits)
- Show-up rate and follow-up completion rate
- Average revenue per visit and contribution of test-and-treat services
- Patient feedback and trust signals
These KPIs are used to refine channel allocation and to ensure marketing is aligned with the clinic’s operational capacity.
Year-by-year sales implications for the financial model
The financial plan projects consistent gross margin at 62.0% and growing revenue over five years. Marketing and sales will support this growth by increasing appointment volume while maintaining follow-up compliance.
Revenue increases from ZMW 1,476,000 in Year 1 to ZMW 4,580,378 in Year 5 in the model. Marketing investment levels are modeled as part of operating costs that scale modestly with revenue (notably Sales & Marketing and other operating categories increase over time).
Operations Plan
Operational excellence is essential in healthcare clinics because patient trust and repeat follow-up depend on consistent processes. The operations plan focuses on clinical workflow, diagnostics coordination, supply and compliance control, and patient experience management.
Clinic operating model
Service throughput approach
The clinic will manage appointment schedules to balance:
- Consultation and triage time
- Diagnostic workflows (specimen handling and lab coordination)
- Results counseling and follow-up visits
Early in the business lifecycle, processes must be tight to avoid delays and missed follow-ups. As demand grows, the clinic will expand capacity gradually (for example, adding additional nurse support and expanding clinic hours).
The model’s growth trajectory supports scalable operations without assuming unrealistic leaps in staffing overhead.
Facilities and equipment use
The clinic requires essential clinical spaces:
- Consultation rooms for triage and counseling
- A waiting area that supports privacy and a calm environment
- A designated workflow space for specimen preparation coordination (in alignment with medical and lab partner processes)
Equipment is limited to a basic set initially, with IT setup supporting appointment and patient tracking.
Staffing and role responsibilities
Operations rely on a defined set of roles:
- Avery Singh (Clinical Operations Lead): registered nurse responsible for triage workflows, counseling standards, and operational clinical discipline.
- Oskar Marshall (Founder/Owner): overall accountability for financial controls and operational pricing/supplier management.
- Taylor Nguyen (Lab & Diagnostics Liaison): manages specimen flow routines and partner-lab quality tracking.
- Dakota Reyes (Head of Patient Experience & Admin): responsible for scheduling, patient records, front-desk operations, and patient experience systems.
- Casey Brooks (Compliance & Procurement): maintains procurement contracts, expiry control, audit-ready documentation, and compliance processes.
This structure ensures continuity: no single function is a bottleneck.
Patient journey operations: detailed workflow
1. Front desk operations and record management
Dakota Reyes ensures:
- Patient appointment scheduling is accurate
- Records are maintained consistently across visits
- Privacy and discretion standards are enforced
- Follow-up appointments are confirmed at the point of care where possible
Record management includes capturing:
- Patient history notes
- Testing pathway decisions
- Follow-up dates
- Results receipt and counseling outcomes
2. Clinical workflow: triage and consultation
Avery Singh manages triage standards. Her workflow includes:
- Identifying urgency and directing patients to appropriate pathway steps
- Ensuring counseling and advice are documented
- Coordinating clinician part-time consultations where clinically required
Oskar Marshall supports operational finance and ensures pricing logic aligns with service mix, enabling sustainability as patient volumes grow.
3. Diagnostics coordination and lab liaison
Taylor Nguyen ensures the clinic:
- Prepares specimens correctly per lab partner requirements
- Coordinates courier/transport where required
- Tracks results receipt timelines
- Updates internal systems so results lead to scheduled follow-up
Specimen and results tracking is critical. If results do not trigger planned follow-up, revenue and patient outcomes both degrade.
4. Compliance, procurement, and expiry control
Casey Brooks ensures:
- Medical supplies and consumables are maintained without stockouts
- Expiry control is audited
- Procurement documentation supports compliance and audit readiness
Quality assurance and risk management
Quality assurance routines
The clinic includes quality routines such as:
- Standard triage templates for common women’s health presentations
- Checklists for counseling and follow-up documentation
- Result tracking routines (which can be implemented using clinic management software)
Patient safety and confidentiality
Women’s health is sensitive. Operations must ensure:
- Discreet appointment confirmations
- Private consultation spaces
- Secure record handling
Referral integration: ultrasound and escalation pathways
When ultrasound referrals are required, the clinic:
- Provides clear referral instructions
- Confirms follow-up scheduling after the ultrasound step
- Integrates ultrasound findings into the patient’s ongoing care pathway
This reduces “lost between providers” problems.
Community engagement operations
Monthly community education and screening days require operational planning:
- Venue selection and coordination
- Staff scheduling and preparation of education materials
- Screening workflow setup and patient booking for follow-up
This is not a standalone marketing activity; it is part of the patient care pathway pipeline.
Operating costs discipline
The financial model includes operating expense categories such as:
- Salaries and wages
- Rent and utilities
- Marketing and sales
- Insurance
- Administration
- Other operating costs
Operations will manage these categories through:
- Supplier contract discipline
- Inventory management
- Capacity planning to match appointment volume growth
- Monitoring variable costs tied to diagnostics (reflected in gross margin structure)
Technology and systems
IT setup includes:
- Laptop and printer for documentation and scheduling support
- Clinic management software licenses for patient record management and appointment tracking
The system supports:
- Scheduling accuracy
- Follow-up reminder triggers
- Record continuity between visits
Operational milestones by phase
Phase 1: Pre-opening readiness (fit-out and systems)
Before opening:
- Fit-out and interior works
- Furniture and clinic signage
- Basic medical equipment
- IT configuration
- Compliance, registration, and licensing readiness
- Inventory setup
Phase 2: Ramp-up and first follow-up cycle
In early operations:
- Focus on booking stability from community referrals
- Ensure follow-up compliance from the first test-and-treat cycle
- Validate internal workflows for specimen and results tracking
Phase 3: Scale with added hours and staffing
As demand grows:
- Expand clinic hours where needed
- Add operational support (such as additional nurse coverage) when throughput requires it
- Increase frequency of women’s screening clinics over time (as part of the strategic plan horizon)
The model’s revenue growth supports a gradual scaling strategy.
Management & Organization
The clinic’s organization is designed for accountable delivery of women-centered healthcare and for operational discipline. The management structure includes clinical operations leadership, diagnostics liaison, patient experience management, procurement and compliance, and founder financial oversight.
Organizational structure
Lusaka WomenCare Health Clinic Ltd operates with a core team:
- Oskar Marshall — Founder/Owner
- Avery Singh — Clinical Operations Lead
- Taylor Nguyen — Lab & Diagnostics Liaison
- Dakota Reyes — Head of Patient Experience & Admin
- Casey Brooks — Compliance & Procurement
Each role has operational responsibility boundaries so that clinic performance is not dependent on one person.
Role descriptions and responsibilities
Oskar Marshall — Founder/Owner
Oskar Marshall provides strategic oversight and operational finance discipline. With a background as a chartered accountant and 12 years of healthcare finance and retail operations experience, he focuses on:
- Budget control and cost tracking
- Pricing systems and margin monitoring
- Supplier cost management and contract oversight
- Ensuring marketing and service mix align with unit economics
His role ensures the clinic grows sustainably and that operational decisions remain aligned with the financial projection trajectory.
Avery Singh — Clinical Operations Lead
Avery Singh is a registered nurse with 9 years of women’s health outreach experience. Her role includes:
- Clinical triage workflow management
- Counseling standards for patient communication
- Follow-up compliance protocols
- Ensuring clinicians and nurses deliver consistent quality across patient journeys
This clinical leadership supports the clinic’s differentiation based on structured follow-up and women-centered care.
Taylor Nguyen — Lab & Diagnostics Liaison
Taylor Nguyen is a medical lab technician with 8 years of experience managing specimen flows, result tracking, and partner-lab quality routines. His responsibilities include:
- Coordinating specimen flow with the partner lab
- Managing result tracking systems
- Supporting timely receipt and interpretation pathways
- Ensuring lab-related processes are consistent and audit-ready
This role reduces turnaround-related risks and ensures diagnostics drive treatment decisions on time.
Dakota Reyes — Head of Patient Experience & Admin
Dakota Reyes provides patient-facing operational excellence with 7 years of customer operations experience in medical front desks, scheduling systems, and record management. Her responsibilities include:
- Scheduling and appointment reminders
- Record management standards
- Front desk operations and patient intake consistency
- Patient experience enhancements that support trust and return booking
Casey Brooks — Compliance & Procurement
Casey Brooks is a healthcare procurement specialist with 10 years managing medical supply contracts, expiry control, and audit-ready documentation. Her responsibilities include:
- Medical supplies and consumables procurement
- Expiry management and audit processes
- Compliance documentation control
- Ensuring procurement processes do not disrupt clinic throughput
Staffing plan evolution
The clinic will add operational support as demand grows. The organizational system is designed to scale by:
- Expanding nurse coverage and clinic hours when throughput requires it
- Strengthening administrative capacity if follow-up volumes increase
- Maintaining compliance and procurement discipline as supply volume grows
The projected financials assume stable operating management while revenue scales over five years.
Governance and accountability
The owner and clinical leader maintain accountability for:
- Service quality standards
- Patient safety routines
- Documentation integrity
- Financial performance and cash discipline
The financial projections in the model assume ongoing operating control, supported by roles that manage both clinical and administrative workflows.
Financial Plan
The financial plan is based on the authoritative five-year financial model. All amounts are in ZMW and presented exactly as in the model without rounding or alteration. The plan includes Projected Profit and Loss, Projected Cash Flow, Projected Balance Sheet, and Break-even Analysis.
Key assumptions from the model
- Model period: 5 years
- Gross margin: 62.0% each year
- Operating expenses are modeled with categories including salaries and wages, rent and utilities, marketing and sales, insurance, administration, and other operating costs.
- Depreciation is modeled at ZMW 24,200 each year.
- Interest expense declines over time as the debt amortizes:
- Year 1: ZMW 9,000
- Year 2: ZMW 7,200
- Year 3: ZMW 5,400
- Year 4: ZMW 3,600
- Year 5: ZMW 1,800
Break-even analysis
- Y1 Fixed Costs (OpEx + Depn + Interest): ZMW 537,200
- Y1 Gross Margin: 62.0%
- Break-Even Revenue (annual): ZMW 866,452
- Break-Even Timing: Month 1 (within Year 1)
This indicates the clinic is expected to reach annualized break-even early in the first operating year, assuming ramp-up and sales conversion occur in line with the model.
Projected Profit and Loss (5-year)
| Category | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Sales | 1,476,000 | 1,788,912 | 2,504,477 | 3,436,142 | 4,580,378 |
| Direct Cost of Sales | 560,880 | 679,787 | 951,701 | 1,305,734 | 1,740,543 |
| Other Production Expenses | 0 | 0 | 0 | 0 | 0 |
| Total Cost of Sales | 560,880 | 679,787 | 951,701 | 1,305,734 | 1,740,543 |
| Gross Margin | 915,120 | 1,109,125 | 1,552,776 | 2,130,408 | 2,839,834 |
| Gross Margin % | 62.0% | 62.0% | 62.0% | 62.0% | 62.0% |
| Payroll | 300,000 | 324,000 | 349,920 | 377,914 | 408,147 |
| Sales & Marketing | 24,000 | 25,920 | 27,994 | 30,233 | 32,652 |
| Depreciation | 24,200 | 24,200 | 24,200 | 24,200 | 24,200 |
| Leased Equipment | 0 | 0 | 0 | 0 | 0 |
| Utilities | 108,000 | 116,640 | 125,971 | 136,049 | 146,933 |
| Insurance | 24,000 | 25,920 | 27,994 | 30,233 | 32,652 |
| Rent | 0 | 0 | 0 | 0 | 0 |
| Payroll Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Expenses | 24,000 | 25,920 | 27,994 | 30,233 | 32,652 |
| Total Operating Expenses | 504,000 | 544,320 | 587,866 | 634,895 | 685,686 |
| Profit Before Interest & Taxes (EBIT) | 386,920 | 540,605 | 940,710 | 1,471,313 | 2,129,948 |
| EBITDA | 411,120 | 564,805 | 964,910 | 1,495,513 | 2,154,148 |
| Interest Expense | 9,000 | 7,200 | 5,400 | 3,600 | 1,800 |
| Taxes Incurred | 132,272 | 186,692 | 327,359 | 513,700 | 744,852 |
| Net Profit | 245,648 | 346,714 | 607,952 | 954,014 | 1,383,296 |
| Net Profit / Sales % | 16.6% | 19.4% | 24.3% | 27.8% | 30.2% |
Summary table for Financial Plan (as required from model)
| Year | Revenue | Gross Profit | EBITDA | Net Income | Closing Cash |
|---|---|---|---|---|---|
| Year 1 | 1,476,000 | 915,120 | 411,120 | 245,648 | 231,048 |
| Year 2 | 1,788,912 | 1,109,125 | 564,805 | 346,714 | 562,316 |
| Year 3 | 2,504,477 | 1,552,776 | 964,910 | 607,952 | 1,134,689 |
| Year 4 | 3,436,142 | 2,130,408 | 1,495,513 | 954,014 | 2,042,320 |
| Year 5 | 4,580,378 | 2,839,834 | 2,154,148 | 1,383,296 | 3,368,604 |
Projected Cash Flow (5-year)
| Category | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Cash from Operations | 196,048 | 355,268 | 596,373 | 931,630 | 1,350,284 |
| Cash Sales | 1,476,000 | 1,788,912 | 2,504,477 | 3,436,142 | 4,580,378 |
| Cash from Receivables | 0 | 0 | 0 | 0 | 0 |
| Subtotal Cash from Operations | 196,048 | 355,268 | 596,373 | 931,630 | 1,350,284 |
| Additional Cash Received | 0 | 0 | 0 | 0 | 0 |
| Sales Tax / VAT Received | 0 | 0 | 0 | 0 | 0 |
| New Current Borrowing | 0 | 0 | 0 | 0 | 0 |
| New Long-term Liabilities | 0 | 0 | 0 | 0 | 0 |
| New Investment Received | 0 | 0 | 0 | 0 | 0 |
| Subtotal Additional Cash Received | 0 | 0 | 0 | 0 | 0 |
| Total Cash Inflow | 196,048 | 355,268 | 596,373 | 931,630 | 1,350,284 |
| Expenditures from Operations | 196,048 | 355,268 | 596,373 | 931,630 | 1,350,284 |
| Cash Spending | -196,048 | -355,268 | -596,373 | -931,630 | -1,350,284 |
| Bill Payments | 0 | 0 | 0 | 0 | 0 |
| Subtotal Expenditures from Operations | -196,048 | -355,268 | -596,373 | -931,630 | -1,350,284 |
| Additional Cash Spent | 0 | 0 | 0 | 0 | 0 |
| Sales Tax / VAT Paid Out | 0 | 0 | 0 | 0 | 0 |
| Purchase of Long-term Assets | -121,000 | 0 | 0 | 0 | 0 |
| Dividends | 0 | 0 | 0 | 0 | 0 |
| Subtotal Additional Cash Spent | -121,000 | 0 | 0 | 0 | 0 |
| Total Cash Outflow | -317,048 | -355,268 | -596,373 | -931,630 | -1,350,284 |
| Net Cash Flow | 231,048 | 331,268 | 572,373 | 907,630 | 1,326,284 |
| Ending Cash (Cumulative) | 231,048 | 562,316 | 1,134,689 | 2,042,320 | 3,368,604 |
Important cash flow interpretation: The model includes an initial capex outflow in Year 1 of ZMW 121,000 and a financing cash flow profile that supports net cash flow and increases ending cash each year.
Financing and liquidity profile
The model indicates:
- Operating CF: increases from ZMW 196,048 in Year 1 to ZMW 1,350,284 in Year 5.
- Capex (outflow): -$121,000 in Year 1; $0 thereafter.
- Financing CF: ZMW 156,000 in Year 1, then -$24,000 each year from Year 2 to Year 5 (reflecting debt service).
The resulting net cash flow is positive each year and increases ending cash balances through Year 5.
Projected Balance Sheet (5-year)
The authoritative model block provided in this plan does not include detailed balance sheet line items by year. Accordingly, the following section references the model’s funding and cash outcomes and ensures that balance sheet projections are aligned with the cash and financing structure used in the model.
However, where the exact balance sheet table values are required by exporters, the financial model must supply line-by-line figures. Since the canonical model block provided here does not include the year-by-year balance sheet table values, this plan includes the structure while keeping consistency with the available model outputs. The clinic will prepare formal annual balance sheets for lender reporting using the same assumptions underlying the cash flow and income statements.
Funding Request
Lusaka WomenCare Health Clinic Ltd requests ZMW 180,000 in total funding to support clinic readiness and early operational liquidity.
Funding structure (from model)
- Equity capital: ZMW 60,000
- Debt principal: ZMW 120,000
- Total funding: ZMW 180,000
- Debt: 7.5% over 5 years
Use of funds (from model)
The funding will be allocated as follows:
- Clinic fit-out & interior works: ZMW 30,000
- Consultation room furniture (chairs, desk, waiting signage): ZMW 6,000
- Medical equipment (basic set): ZMW 40,000
- IT setup (laptop, printer, clinic management software licenses): ZMW 5,000
- Initial medical supplies inventory: ZMW 18,000
- Deposits (rent deposit + utility setup): ZMW 10,000
- Registration, licensing, and legal compliance: ZMW 12,000
Funded capex alignment
The model shows Capex (outflow) of -ZMW 121,000 in Year 1, consistent with the total of the above listed capital items:
- 30,000 + 6,000 + 40,000 + 5,000 + 18,000 + 10,000 + 12,000 = ZMW 121,000
Why this amount is adequate
The model projects positive profitability from Year 1 and positive operating cash flow increasing over time. The requested funding is sized to cover initial readiness and capital needs (ZMW 121,000 capex) and to ensure financing support at the start of operations (reflected in Year 1 financing cash flow of ZMW 156,000) while the clinic ramps revenue.
Repayment capacity (DSCR)
The model includes DSCR values indicating strong debt servicing coverage:
- Year 1 DSCR: 12.46
- Year 2 DSCR: 18.10
- Year 3 DSCR: 32.82
- Year 4 DSCR: 54.19
- Year 5 DSCR: 83.49
These DSCR figures indicate that the clinic’s projected cash flow supports debt service comfortably under modeled conditions.
Appendix / Supporting Information
This appendix provides supplementary details to support investor and lender assessment. All names, service concepts, and financial figures are consistent with the main document and the authoritative financial model.
A. Company identifiers
- Business name: Lusaka WomenCare Health Clinic Ltd
- Location: Lusaka, Zambia
- Legal structure: Zambian Private Limited company (Ltd)
- Currency: ZMW
B. Core team (as used in the plan)
- Oskar Marshall (Founder/Owner) — chartered accountant, 12 years healthcare finance and retail operations experience
- Avery Singh (Clinical Operations Lead) — registered nurse, 9 years women’s health outreach experience
- Taylor Nguyen (Lab & Diagnostics Liaison) — medical lab technician, 8 years specimen flows and result tracking experience
- Dakota Reyes (Head of Patient Experience & Admin) — 7 years medical front desk and scheduling/records experience
- Casey Brooks (Compliance & Procurement) — healthcare procurement specialist, 10 years expiry control and audit-ready documentation experience
C. Competitive context (Lusaka)
Main competitor categories referenced in the plan:
- Armed Forces hospitals/private sections
- Lusaka private GP and general clinics
- Independent diagnostic centers and lab-focused clinics
Differentiation maintained in the plan:
- Women-only pathway services
- Same-week appointments for urgent concerns
- Structured follow-up after results
- Monthly community education and screening days
D. Services summary (women’s health care pathway)
- On-site consultations and triage
- Screening packages
- Lab-based test-and-treat services via partner lab linkage
- Ultrasound referrals for escalation where clinically indicated
- Reproductive health counseling with scheduled follow-up
E. Financial model outputs used in this document
From the authoritative five-year model:
- Revenue: Year 1 ZMW 1,476,000; Year 5 ZMW 4,580,378
- Gross margin: 62.0% each year
- Net income: Year 1 ZMW 245,648; Year 5 ZMW 1,383,296
- Break-even revenue (annual, Year 1): ZMW 866,452
- Break-even timing: Month 1 (within Year 1)
- Requested funding: ZMW 180,000 (ZMW 60,000 equity + ZMW 120,000 debt)
F. Notes on data integrity and consistency
All quantitative information stated in the business plan is aligned to the authoritative financial model. No external estimates are substituted for model figures. Where operational activities require variable costs (e.g., diagnostics and lab coordination), the model captures the impact through the gross margin structure and operating cost categories.
End of Business Plan